Mirum Pharmaceuticals, Inc. MIRM Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s net debt?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net debt of -$247.93M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s net debt changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net debt decreased by 42.8% year-over-year, from -$173.61M to -$247.93M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net debt?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s net debt has grown at a 12.0% compound annual growth rate (CAGR), from -$138.82M to -$244.72M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.